DOCSLIB.ORG

Microfluidics Coupled Mass Spectrometry for Multi- Omics/Targeted Assays in Translational Research

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Microfluidics Coupled Mass Spectrometry for Multi- Omics/Targeted Assays in Translational Research MICROFLUIDICS COUPLED MASS SPECTROMETRY FOR MULTI- OMICS/TARGETED ASSAYS IN TRANSLATIONAL RESEARCH PD Rainville1, G Astarita1, JP Murphy1, ID Wilson2, JI Langridge1 1Waters Corporation, Milford, MA; 2Imperial College, London, United Kingdom INTRODUCTION Lipidomics of human plasma RESULTS Translation medicine is an interdisciplinary science that Sample Preparation Human plasma samples were prepared by modified Bligh-Dyer extraction with aims at combining the information taken from bench to Figure 4. BPI of multiple- bedside. In this process molecules are isolated and chloroform : methanol (2:1) with a (4:1) with human plasma. The samples were then centrifuged at 13,000 RCF for 5 min, dried down, reconstituted and omics experiments from identified in discovery and then utilized in the clinical injected onto the LC-MS system. human urine and plasma setting as biomarkers of health and disease to better run consecutively. The develop therapies. It has become recently apparent that LC-MS profiling of biofluids was carried out in repetitive proteomics, metabolomics, lipidomics, and glycomics data A 1 µL injection was made onto the LC-MS system. The sample was eluted order of polar plasma under gradient conditions with aqueous formic acid/acetonitrile (40/60) and combined are necessary to address the challenge of profiling, plasma acetonitrile/isopropanol (10/90) at a flow rate of 3 µL/min. Separation was translational research which places strain on available lipidomics, and urine carried out on an iKey CSH C18 100 Å, 1.7µm, 150 µm x 100 mm controlled 1-4 profiling over a period of sample and instrument utilization . Due to the at 60 °C. Mass spectrometry was carried out on the Synapt G2 S in full scan one week. A targeted complexity of deriving meaningful information from these mode from m/z 50-1200 in ESI + ionization mode. analysis of oxytocin was studies, the development of new analytical technologies 5,6 Oxytocin targeted assay carried out at regular is critical . Here we present the utilization of a intervals to monitor the microfluidic LC coupled with mass spectrometry for both Sample preparation robustness of the discovery and targeted studies in translational research. Oxytocin was spiked into human plasma prepared by protein precipitation system. In each of the followed by solid-phase extraction (SPE) The eluent from the SPE was then experiments the optimal removed an injected onto the LC-MS system. conditions where chosen to separate and detect LC-MS analytes from a specific biofluid sample. A 1 µL injection was made onto the LC-MS system. The sample was eluted under gradient conditions with aqueous formic acid and acetonitrile at a flow rate of 3 µL/min. Separation was carried out on an PST C18 120 Å, 1.7µm, 150 µm x 100 mm controlled at 60 °C. Mass spectrometry was carried out on Figure 5. Zoomed BPI the Synapt G2 S TOF MRM and in ESI + ionization mode. from human urine profiling experiment shown in Figure 4, illustrating the ability of microfluidic LC-MS to separate highly complex samples with good chroma- tographic resolution. Average peak widths at base for the peaks in the time space is 4.2 s. Figure 1. Schematic of microfluidic LC-MS system utilized in this study. CONCLUSIONS The analysis of multiple preparations from plasma and Figure 2. Profiling of biofluids can strain available sample volumes. The profiling urine for multi-omics studies was successfully carried out METHODS of biofluids for the purposes of better understanding the influence of a medicine, in consecutive repetitive order illustrating the robustness disease or health state can require multiple tests. Samples from subjects may and applicability of microfluidic LC-MS for profiling Instrumentation require analysis by a number of analytical methodologies including NMR and LC-MS. The result of this can be strain on the available amount of sample and experiments ACQUITY UPLC M-Class System therefore may restrict the amount of meaningful information that could be Microfluidic LC-MS has the ability to separate Xevo TQ S derived from subjects in a study. This can be especially true during pre-clinical complex samples and produce average peak widths Synapt G2 S testing of rodent models such as mice. of 4.2 s at peak base producing peak capacity of 143 for a Reagents 10 min separation Oxytocin, ammonium formate, formic acid and were obtained from Sigma Al- Separation of tryptic peptides on multiple microfluidic drich Chemicals (St Louis, MO). Acetonitrile, chloroform and methanol was devices illustrated good reproducibility with retention purchased from JT Baker Chemicals (Phillipsburg, USA). Distilled water was time %RSD below 0.6% for all devices tested produced in house using a MilliQ system (Millipore, MA). Human plasma was obtained from Equitech Bio (Kerrville, TX) Trypsin was obtained from Promega The robustness, reproducibility and ability to analyze (Maddison, WI). Human urine was collected from willing volunteers. multiple preparations of biofluids for multi-omics experiments indicates that the use of microfluidic Metabolomics of human urine and plasma LC-MS may play a future key role in the development of Sample preparation translational and personalized medicine Human urine samples were prepared by dilution with water (1:4) and centri- fuged at 13,000 RCF for 5 min. The supernatant was then removed an in- jected onto the LC-MS system. Human plasma samples were prepared by pro- References tein precipitation with methanol (1:2) and centrifuged at 13,000 RCF for 5 1. Nie et al. Advaced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of heptocellular carcinoma. Mass Spectrom Rev (2014) min. The supernatant was then removed, and injected onto the LC-MS sys- 2. Stuani et al. A., Novel metabolic features in Acinetobacter baylyi ADP1 revealed by a multomics tem. approach. Metabolomics 10 (6) 1223-1238 (2014) 3. Higdon et al. The promise of multi-omics and clinical data integration to identify and target LC-MS personalized healthcare approaches in autism spectrum disorders. Omics 19 (4) 197-208 (2015) Figure 3. Increases in sensitivity for pharmaceutical peptides, biomarker 4. Goldberg et al. Proteomic and other mass spectrometry based-omics biomarker discovery and A 1 µL injection was made onto the LC-MS system. The sample was eluted peptides, and tryptic digest peptides. The graph illustrates the average signal-to validation in pediatric venous thromboembolism and arterial ischemic stroke: current state, under gradient conditions with aqueous formic acid and acetonitrile at a flow unmet needs, and future direction. Proteomics Clin Appl 8 911-12) 826-836 (2014). -noise and area counts (n=6) for various peptides analyzed by microfluidic 5. Chetwynd et al. Solid Phase Extraction and Nanoflow Liquid Chromatography-Nanoelectrospray rate of 3 µL/min. Separation was carried out on an iKey HSS T3, 100 Å, LC-MS compared with traditional 2.1 mm i.d. UPLC-MS. Significant increases in ionization mass spectrometry for improved global urine metabolomics. Anal. Chem. 87, 1158- 1.7µm, 150 µm x 100 mm controlled at 40 °C. Mass spectrometry was carried both area count and signal-to-noise were produced by the microfluidic LC-MS. 1165 (2015) 6. Want et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc. 5 (6), out on the Synapt G2 S in full scan mode from m/z 50-1200 in ESI + ioniza- This inherent gain in sensitivity may therefore enable both the use of less 1005-1018 (2010) tion mode. sample and better use of limited sample volumes for multiple analysis or increase the ability to detect analytes from limited available sample volumes. TO DOWNLOAD A COPY OF THIS POSTER, VISIT WWW.WATERS.COM/POSTERS ©2015 Waters Corporation | LL-pdf .
Load more

Recommended publications
  • Recent Advances in Droplet-Based Microfluidic Technologies
    micromachines Review Recent Advances in Droplet-based Microfluidic Technologies for Biochemistry and Molecular Biology 1, 1, 2, Joel Sánchez Barea y , Juhwa Lee y and Dong-Ku Kang * 1 Department of Chemistry, Incheon National University, Incheon 22012, Korea; [email protected] (J.S.B.); [email protected] (J.L.) 2 Department of Chemistry, Research Institute of Basic Sciences, Incheon National University, Incheon 22012, Korea * Correspondence: [email protected]; Tel.: +82-32-835-8094 These authors contribute equally to this article. y Received: 2 May 2019; Accepted: 18 June 2019; Published: 20 June 2019 Abstract: Recently, droplet-based microfluidic systems have been widely used in various biochemical and molecular biological assays. Since this platform technique allows manipulation of large amounts of data and also provides absolute accuracy in comparison to conventional bioanalytical approaches, over the last decade a range of basic biochemical and molecular biological operations have been transferred to drop-based microfluidic formats. In this review, we introduce recent advances and examples of droplet-based microfluidic techniques that have been applied in biochemistry and molecular biology research including genomics, proteomics and cellomics. Their advantages and weaknesses in various applications are also comprehensively discussed here. The purpose of this review is to provide a new point of view and current status in droplet-based microfluidics to biochemists and molecular biologists. We hope that this review will accelerate communications between researchers who are working in droplet-based microfluidics, biochemistry and molecular biology. Keywords: droplet-based microfluidic; biochemistry; molecular biology; digital PCR; biochip; biosensor; digital quantification; microfluidic; single cell analysis 1.
    [Show full text]
  • Serum N-Glycomics Stratifies Bacteremic Patients Infected With
    Journal of Clinical Medicine Article Serum N-Glycomics Stratifies Bacteremic Patients Infected with Different Pathogens Sayantani Chatterjee 1,2 , Rebeca Kawahara 1,2, Harry C. Tjondro 1,2, David R. Shaw 3, Marni A. Nenke 4,5,6, David J. Torpy 4,5 and Morten Thaysen-Andersen 1,2,* 1 Department of Molecular Sciences, Macquarie University, Sydney, NSW 2109, Australia; [email protected] (S.C.); [email protected] (R.K.); [email protected] (H.C.T.) 2 Biomolecular Discovery Research Centre, Macquarie University, Sydney, NSW 2109, Australia 3 Infectious Diseases Clinic, Royal Adelaide Hospital, Adelaide, SA 5000, Australia; [email protected] 4 Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA 5000, Australia; [email protected] (M.A.N.); [email protected] (D.J.T.) 5 School of Medicine, University of Adelaide, Adelaide, SA 5000, Australia 6 Department of Endocrinology and Diabetes, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia * Correspondence: [email protected]; Tel.: +61-2-9850-7487; Fax: +61-2-9850-6192 Abstract: Bacteremia—i.e., the presence of pathogens in the blood stream—is associated with long- term morbidity and is a potential precursor condition to life-threatening sepsis. Timely detection of bacteremia is therefore critical to reduce patient mortality, but existing methods lack precision, speed, and sensitivity to effectively stratify bacteremic patients. Herein, we tested the potential of quantitative serum N-glycomics performed using porous graphitized carbon liquid chromatography tandem mass spectrometry to stratify bacteremic patients infected with Escherichia coli (n = 11), Citation: Chatterjee, S.; Kawahara, Staphylococcus aureus (n = 11), Pseudomonas aeruginosa (n = 5), and Streptococcus viridans (n = 5) from R.; Tjondro, H.C.; Shaw, D.R.; Nenke, healthy donors (n = 39).
    [Show full text]
  • Glycomics Meets Genomics, Epigenomics and Other High Throughput Omics for System Biology Studies
    COCHBI-1014; NO. OF PAGES 7 Available online at www.sciencedirect.com Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies 1 1 2,3 Vlatka Zoldosˇ , Tomislav Horvat and Gordan Lauc Majority of eukaryotic proteins are glycosylated and their Both inherited (genetic) and acquired (environmental) glycan moieties have numerous important structural, functional factors that modulate glycosylation affect numerous mol- and regulatory roles. Because of structural complexity of ecular processes, including interactions with specific glycans and technological limitations glycomics, and receptors or half-life of numerous membrane proteins particularly glycoproteomics was not able to follow rapid [3]. Both quantitative and qualitative changes in the progress in genomics and proteomics over last 30 years. repertoire of glycan structures have been found in many However, the field of glycan has been progressing rapidly and complex diseases and cancer [4]. However, due to the first large-scale studies of the glycome have been completed structural complexity of glycans and technological limita- recently. These studies have revealed significant differences in tions the knowledge of functional importance of glycans glycome composition between individuals, which may is significantly lagging behind the knowledge of DNA and contribute to the human phenotypic variability. The current proteins. state-of-the-art in high-throughput glycomics and its integration with genomics, epigenomics and lipidomics is The development of high-throughput reviewed in this article. quantitative glycomic analysis Addresses Until only a few years ago glycan analysis was extremely 1 University of Zagreb, Faculty of Science, Zagreb, Croatia 2 laborious and complex, hampering large-scale studies of University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia the glycome.
    [Show full text]
  • Interfacing to Biological Systems Using Microfluidics
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 12-2018 Interfacing to Biological Systems Using Microfluidics Peter Golden Shankles University of Tennessee, [email protected] Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Recommended Citation Shankles, Peter Golden, "Interfacing to Biological Systems Using Microfluidics. " PhD diss., University of Tennessee, 2018. https://trace.tennessee.edu/utk_graddiss/5315 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Peter Golden Shankles entitled "Interfacing to Biological Systems Using Microfluidics." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Energy Science and Engineering. Scott T. Retterer, Major Professor We have read this dissertation and recommend its acceptance: Steven M. Abel, Mitchel J. Doctycz, Jennifer L. Morrell-Falvey Accepted for the Council: Dixie L. Thompson Vice Provost and Dean of the Graduate School (Original signatures are on file with official studentecor r ds.) Interfacing to Biological Systems Using Microfluidics A Dissertation Presented for the Doctor of Philosophy Degree The University of Tennessee, Knoxville Peter Golden Shankles December 2018 Copyright © 2018 by Peter Golden Shankles All rights reserved.
    [Show full text]
  • Insights of New Tools in Glycomics Research Denong Wang1 * and Srinubabu Gedela2,3
    Journal of Proteomics & Bioinformatics - Open Access Editorial JPB/Vol.1/November 2008 Insights of New Tools In Glycomics Research Denong Wang1 * and Srinubabu Gedela2,3 1Stanford Tumor Glycome Laboratory, Stanford University School of Medicine, Beckman Center, Rm B006, 279 Campus Drive, Stanford, CA 94305-5120, USA 2Center for Biotechnology & International Center for Bioinformatics, Andhra University College of Engineering, Visakhapatnam-530003, India. 3Institute of Glycoproteomics & Systems Biology, Andhra Pradesh, India *Corresponding authors: Denong Wang, Stanford Tumor Glycome Laboratory, Stanford University School of Medicine, Beckman Center, Rm B006, 279 Campus Drive, Stanford, CA 94305-5120, USA, E-mail: [email protected] Srinubabu Gedela: [email protected] Received November 01, 2008; Accepted November 04, 2008; Published November 05, 2008 Citation: Denong W, Srinubabu G (2008) Insights of New tools in Glycomics Research. J Proteomics Bioinform 1: 374-378. doi:10.4172/jpb.1000046 Copyright: © 2008 Denong W, Srinubabu G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Since the origin of Journal of Proteomics & Bioinformatics the equivalence of papers published from different –omics disciplines is steadfast. The present editorial describes the new tools in glycomics research. -omics era Completion of the genome sequencing projects not only on the outer surfaces of the majority of viral, bacterial, pro- provides insight into the complex origin, history and related- tozoan and fungal pathogens. Many sugar structures are ness of the species, but also helps in understanding molecu- pathogen-specific, which makes them important molecular lar pathology of genetic diseases.
    [Show full text]
  • A Flexible Microfluidic System for Single-Cell Transcriptome Profiling
    www.nature.com/scientificreports OPEN A fexible microfuidic system for single‑cell transcriptome profling elucidates phased transcriptional regulators of cell cycle Karen Davey1,7, Daniel Wong2,7, Filip Konopacki2, Eugene Kwa1, Tony Ly3, Heike Fiegler2 & Christopher R. Sibley 1,4,5,6* Single cell transcriptome profling has emerged as a breakthrough technology for the high‑resolution understanding of complex cellular systems. Here we report a fexible, cost‑efective and user‑ friendly droplet‑based microfuidics system, called the Nadia Instrument, that can allow 3′ mRNA capture of ~ 50,000 single cells or individual nuclei in a single run. The precise pressure‑based system demonstrates highly reproducible droplet size, low doublet rates and high mRNA capture efciencies that compare favorably in the feld. Moreover, when combined with the Nadia Innovate, the system can be transformed into an adaptable setup that enables use of diferent bufers and barcoded bead confgurations to facilitate diverse applications. Finally, by 3′ mRNA profling asynchronous human and mouse cells at diferent phases of the cell cycle, we demonstrate the system’s ability to readily distinguish distinct cell populations and infer underlying transcriptional regulatory networks. Notably this provided supportive evidence for multiple transcription factors that had little or no known link to the cell cycle (e.g. DRAP1, ZKSCAN1 and CEBPZ). In summary, the Nadia platform represents a promising and fexible technology for future transcriptomic studies, and other related applications, at cell resolution. Single cell transcriptome profling has recently emerged as a breakthrough technology for understanding how cellular heterogeneity contributes to complex biological systems. Indeed, cultured cells, microorganisms, biopsies, blood and other tissues can be rapidly profled for quantifcation of gene expression at cell resolution.
    [Show full text]
  • RNA-Seq and Microfluidic Digital PCR Identification of Transcriptionally Active Spirochetes in Termite Gut Microbial Communities
    4-1 RNA-Seq and microfluidic digital PCR identification of transcriptionally active spirochetes in termite gut microbial communities Abstract CO2-reductive acetogenesis in termite hindguts is a bacterial process with significant impact on the nutrition of wood-feeding termites. Acetogenic spirochetes have been identified as key mediators of acetogenesis. Here, we use high-throughput, short transcript sequencing (RNA-Seq) and microfluidic, multiplex digital PCR to identify uncultured termite gut spirochetes transcribing genes for hydrogenase-linked formate dehydrogenase (FDHH) enzymes, which are required for acetogenic metabolism in the spirochete, Treponema primitia. To assess FDHH gene (fdhF) transcription within the gut community of a wood-feeding termite, we sequenced ca. 28,000,000 short transcript reads of gut microbial community RNA using Illumina Solexa technology. RNA-Seq results indicate that fdhF transcription in the gut is dominated by two fdhF genotypes: ZnD2sec and Zn2cys. This finding was independently corroborated with cDNA inventory and qRT-PCR transcription measurements. We, therefore, propose that RNA-Seq mapping of microbial community transcripts is specific and quantitative. Following transcriptional assessments, we performed microfluidic, multiplex digital PCR on single termite gut bacterial cells to discover the identity of uncultured bacteria encoding fdhF 4-2 genotypes ZnD2sec and Zn2cys. We identified the specific 16S rRNA gene ribotype of the bacterium encoding Zn2cys fdhF and report that the bacterium is a spirochete. Phylogenetic analysis reveals that this uncultured spirochete, like T. primitia, possesses genes for acetogenic metabolism – formyl-tetra-hydrofolate synthetase and both selenocysteine and cysteine variants of formate dehydrogenase. Microfluidic results also imply a spirochetal origin for ZnD2sec fdhF, but further gene pair associations are required for verification.
    [Show full text]
  • Microbes and Metagenomics in Human Health an Overview of Recent Publications Featuring Illumina® Technology TABLE of CONTENTS
    Microbes and Metagenomics in Human Health An overview of recent publications featuring Illumina® technology TABLE OF CONTENTS 4 Introduction 5 Human Microbiome Gut Microbiome Gut Microbiome and Disease Inflammatory Bowel Disease (IBD) Metabolic Diseases: Diabetes and Obesity Obesity Oral Microbiome Other Human Biomes 25 Viromes and Human Health Viral Populations Viral Zoonotic Reservoirs DNA Viruses RNA Viruses Human Viral Pathogens Phages Virus Vaccine Development 44 Microbial Pathogenesis Important Microorganisms in Human Health Antimicrobial Resistance Bacterial Vaccines 54 Microbial Populations Amplicon Sequencing 16S: Ribosomal RNA Metagenome Sequencing: Whole-Genome Shotgun Metagenomics Eukaryotes Single-Cell Sequencing (SCS) Plasmidome Transcriptome Sequencing 63 Glossary of Terms 64 Bibliography This document highlights recent publications that demonstrate the use of Illumina technologies in immunology research. To learn more about the platforms and assays cited, visit www.illumina.com. An overview of recent publications featuring Illumina technology 3 INTRODUCTION The study of microbes in human health traditionally focused on identifying and 1. Roca I., Akova M., Baquero F., Carlet J., treating pathogens in patients, usually with antibiotics. The rise of antibiotic Cavaleri M., et al. (2015) The global threat of resistance and an increasingly dense—and mobile—global population is forcing a antimicrobial resistance: science for interven- tion. New Microbes New Infect 6: 22-29 1, 2, 3 change in that paradigm. Improvements in high-throughput sequencing, also 2. Shallcross L. J., Howard S. J., Fowler T. and called next-generation sequencing (NGS), allow a holistic approach to managing Davies S. C. (2015) Tackling the threat of anti- microbial resistance: from policy to sustainable microbes in human health.
    [Show full text]
  • 1 Metabolomic and Glycomic Findings in Posttraumatic Stress Disorder Marcela Konjevoda, Lucija Tudora, Dubravka Svob Straca
    CORE Metadata, citation and similar papers at core.ac.uk Metabolomic and glycomic findings in posttraumatic stress disorder Marcela Konjevoda, Lucija Tudora, Dubravka Svob Straca, Gordana Nedic Erjaveca,b, Coral Barbasb, Neven Zarkovica, Matea Nikolac Perkovica, Suzana Uzunc,d, Oliver Kozumplikc,d, Gordan Lauce, Nela Pivaca,* aRudjer Boskovic Institute, Division of Molecular Medicine, Bijenicka cesta 54, 10000 Zagreb, Croatia bThe Centre of Metabolomics and Bioanalysis (CEMBIO), University San Pablo CEU, Urbanización Montepríncipe, 28660 Boadilla del Monte, Madrid, Spain cClinic for Psychiatry Vrapce, Bolnicka cesta 32, 10000 Zagreb, Croatia dUniversity Josip Juraj Strossmayer Osijek, School of Medicine, Trg Svetog Trojstva 3, 31000 Osijek, Croatia eGENOS, Glycoscience Research Laboratory, Borongajska cesta 83, 10000 Zagreb, Croatia *Correspondence to: Professor Nela Pivac, PhD, Senior Scientist Division of Molecular Medicine Rudjer Boskovic Institute Bijenicka cesta 54, 10 000 Zagreb, Croatia Phone: + 385 1 457 1207; Fax: + 385 1 456 1010 E-mail: [email protected] 1 Abstract Posttraumatic stress disorder (PTSD) is a stressor-related disorder that develops in a subset of individuals exposed to a traumatic experience. Factors associated with vulnerability to PTSD are still not fully understood. PTSD is frequently comorbid with various psychiatric and somatic disorders, moderate response to treatment and remission rates. The term “theranostics” combines diagnosis, prognosis, and therapy and offers targeted therapy based on specific analyses.
    [Show full text]
  • Experimental Section
    EXPERIMENTAL SECTION Detailed description of N-glycomics analysis. N-glycan release from plasma samples The N-glycan release of the discovery set was performed in microcentrifuge tubes, while the glycan release of the testing set was performed in 96-well plates. Both methods were shown to perform similarly (Supplementary Figure 3). The procedures are the same and similar to previously published methods (1, 2). Briefly, 25 μL of a 200mM ammonium bicarbonate (Sigma-Aldrich, St. Louis, MO) solution with 10 mM dithiothreitol (DTT, Promega, Madison, WI) was added to 25 μL of plasma. For the discovery set, this was performed in microcentrifuge tubes; for the testing set, this was performed in 96-well plates. Proteins in the samples were denatured using six cycles alternating between 100°C and room temperature (RT) for 10 seconds each. One µL of PNGaseF (New England Biolabs, Ipswich, MA, corresponding to 1000 NEB units or 15 IUB mU) was added to the samples, and enzymatic glycan release was performed for the discovery set in a CEM (Matthews, NC) microwave at 20W for 10 min. Enzymatic release was performed in batches of 23 samples and one standard serum, to allow quality control. For the testing set, glycan release was performed overnight (16h) at 37°C and a standard serum sample was included in the plate after every ten samples to allow quality control. Upon glycan release, deglycosylated proteins were precipitated using 200 µL of ice-cold ethanol, and the samples were chilled at -80°C for 1 hour. Upon centrifugation, the supernatant was transferred, and dried in vacuo.
    [Show full text]
  • Semantics of Data for Life Sciences and Reproducible Research[Version 1
    F1000Research 2020, 9:136 Last updated: 16 AUG 2021 OPINION ARTICLE BioHackathon 2015: Semantics of data for life sciences and reproducible research [version 1; peer review: 2 approved] Rutger A. Vos 1,2, Toshiaki Katayama 3, Hiroyuki Mishima4, Shin Kawano 3, Shuichi Kawashima3, Jin-Dong Kim3, Yuki Moriya3, Toshiaki Tokimatsu5, Atsuko Yamaguchi 3, Yasunori Yamamoto3, Hongyan Wu6, Peter Amstutz7, Erick Antezana 8, Nobuyuki P. Aoki9, Kazuharu Arakawa10, Jerven T. Bolleman 11, Evan Bolton12, Raoul J. P. Bonnal13, Hidemasa Bono 3, Kees Burger14, Hirokazu Chiba15, Kevin B. Cohen16,17, Eric W. Deutsch18, Jesualdo T. Fernández-Breis19, Gang Fu12, Takatomo Fujisawa20, Atsushi Fukushima 21, Alexander García22, Naohisa Goto23, Tudor Groza24,25, Colin Hercus26, Robert Hoehndorf27, Kotone Itaya10, Nick Juty28, Takeshi Kawashima20, Jee-Hyub Kim28, Akira R. Kinjo29, Masaaki Kotera30, Kouji Kozaki 31, Sadahiro Kumagai32, Tatsuya Kushida 33, Thomas Lütteke 34,35, Masaaki Matsubara 36, Joe Miyamoto37, Attayeb Mohsen 38, Hiroshi Mori39, Yuki Naito3, Takeru Nakazato3, Jeremy Nguyen-Xuan40, Kozo Nishida41, Naoki Nishida42, Hiroyo Nishide15, Soichi Ogishima43, Tazro Ohta3, Shujiro Okuda44, Benedict Paten45, Jean-Luc Perret46, Philip Prathipati38, Pjotr Prins47,48, Núria Queralt-Rosinach 49, Daisuke Shinmachi9, Shinya Suzuki 30, Tsuyosi Tabata50, Terue Takatsuki51, Kieron Taylor 28, Mark Thompson52, Ikuo Uchiyama 15, Bruno Vieira53, Chih-Hsuan Wei12, Mark Wilkinson 54, Issaku Yamada 36, Ryota Yamanaka55, Kazutoshi Yoshitake56, Akiyasu C. Yoshizawa50, Michel
    [Show full text]
  • Glycomics Hits the Big Time
    Leading Edge Essay Glycomics Hits the Big Time Gerald W. Hart1,* and Ronald J. Copeland1 1Department of Biological Chemistry, School of Medicine, Johns Hopkins University, 725 North Wolfe Street, Baltimore, MD 21205-2185, USA *Correspondence: [email protected] DOI 10.1016/j.cell.2010.11.008 Cells run on carbohydrates. Glycans, sequences of carbohydrates conjugated to proteins and lipids, are arguably the most abundant and structurally diverse class of molecules in nature. Recent advances in glycomics reveal the scope and scale of their functional roles and their impact on human disease. By analogy to the genome, transcriptome, O-GlcNAc (Hart et al., 2007). Even though Dynamic Structural Complexity or proteome, the ‘‘glycome’’ is the the generic term ‘‘glycosylation’’ is often Underlies Glycan Functions complete set of glycans and glycoconju- used to categorize and lump all glycan Glycoconjugates provide dynamic struc- gates that are made by a cell or organism modifications of proteins into one bin, tural diversity to proteins and lipids that under specific conditions. Therefore, side by side with other posttranslational is responsive to cellular phenotype, to ‘‘glycomics’’ refers to studies that attempt modifications such as phosphorylation, metabolic state, and to the developmental to define or quantify the glycome of a cell, acetylation, ubiquitination, or methylation, stage of cells. Complex glycans play crit- tissue, or organism (Bertozzi and Sasise- such a view is not only inaccurate, but ical roles in intercellular and intracellular kharan, 2009). In eukaryotes, protein also is completely misleading. If one only processes, which are fundamentally glycosylation generally involves the cova- considers the linkage of the first glycan important to the development of multicel- lent attachment of glycans to serine, to the polypeptide in both prokaryotic lularity (Figure 1).
    [Show full text]